RETRACTED: MMP-9 Induces CD44 Cleavage and CD44 Mediated Cell Migration in Glioblastoma Xenograft Cells

Overview

Journal Cell Signal

Date 2011 Oct 26

PMID 22024282

Citations 65

Authors

Chandramu Chetty

Sravan K Vanamala

Christopher S Gondi

Dzung H Dinh

Meena Gujrati

Jasti S Rao

Affiliations

Soon will be listed here.

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor in Chief. On behalf the University of Illinois at Chicago, the Associate Vice Chancellor and Research Integrity Officer requested retraction of the article because of the elements listed here that were deemed false: Figure 5B, bottom row, Columns 1, 2, 4 and 5, top panel; Figure 5B, Row 1, Columns 1 and 2, bottom panel; Figure 5B, Row 2, Columns 3 and 4 bottom panel. Based on these circumstances the Editor in Chief has therefore decided to retract the paper. The corresponding author has been non-responsive to approaches from the Publisher.

Citing Articles

Clinical implications of heat shock protein 70 in oral carcinogenesis and prediction of progression and recurrence in oral squamous cell carcinoma patients: a retrospective clinicopathological study.

Elhendawy H Eur J Med Res. 2023; 28(1):464.

PMID: 37884988 PMC: 10604814. DOI: 10.1186/s40001-023-01433-8.

Recapitulating thyroid cancer histotypes through engineering embryonic stem cells.

Veschi V, Turdo A, Modica C, Verona F, Di Franco S, Gaggianesi M Nat Commun. 2023; 14(1):1351.

PMID: 36906579 PMC: 10008571. DOI: 10.1038/s41467-023-36922-1.

A Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Assay Identifies Nilotinib as an Inhibitor of Inflammation in Acute Myeloid Leukemia.

Marin-Rubio J, Peltier-Heap R, Duenas M, Heunis T, Dannoura A, Inns J J Med Chem. 2022; 65(18):12014-12030.

PMID: 36094045 PMC: 9511480. DOI: 10.1021/acs.jmedchem.2c00671.

CD44: A Multifunctional Mediator of Cancer Progression.

Hassn Mesrati M, Syafruddin S, Mohtar M, Syahir A Biomolecules. 2021; 11(12).

PMID: 34944493 PMC: 8699317. DOI: 10.3390/biom11121850.

The scrambled story between hyaluronan and glioblastoma.

Pibuel M, Poodts D, Diaz M, Hajos S, Lompardia S J Biol Chem. 2021; 296:100549.

PMID: 33744285 PMC: 8050860. DOI: 10.1016/j.jbc.2021.100549.

References

Ahmed N, Pansino F, Clyde R, Murthi P, Quinn M, Rice G . Overexpression of alpha(v)beta6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade. Carcinogenesis. 2002; 23(2):237-44. DOI: 10.1093/carcin/23.2.237. View

Desai B, Rogers M, Chellaiah M . Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells. Mol Cancer. 2007; 6:18. PMC: 1828067. DOI: 10.1186/1476-4598-6-18. View

Chetty C, Lakka S, Bhoopathi P, Gondi C, Veeravalli K, Fassett D . Urokinase plasminogen activator receptor and/or matrix metalloproteinase-9 inhibition induces apoptosis signaling through lipid rafts in glioblastoma xenograft cells. Mol Cancer Ther. 2010; 9(9):2605-17. PMC: 2937072. DOI: 10.1158/1535-7163.MCT-10-0245. View

Rao J . Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer. 2003; 3(7):489-501. DOI: 10.1038/nrc1121. View

Okamoto I, Kawano Y, Tsuiki H, Sasaki J, Nakao M, Matsumoto M . CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration. Oncogene. 1999; 18(7):1435-46. DOI: 10.1038/sj.onc.1202447. View

Wei K, Huang C, Chen P, Feng L, Wu T, Chen S . Evaluation of the prognostic value of CD44 in glioblastoma multiforme. Anticancer Res. 2010; 30(1):253-9. View

Giese A, Bjerkvig R, Berens M, Westphal M . Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol. 2003; 21(8):1624-36. DOI: 10.1200/JCO.2003.05.063. View

Yu Q, Stamenkovic I . Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev. 1999; 13(1):35-48. PMC: 316376. DOI: 10.1101/gad.13.1.35. View

Kawano Y, Okamoto I, Murakami D, Itoh H, Yoshida M, Ueda S . Ras oncoprotein induces CD44 cleavage through phosphoinositide 3-OH kinase and the rho family of small G proteins. J Biol Chem. 2000; 275(38):29628-35. DOI: 10.1074/jbc.M002440200. View

10.

Wang S, Wong G, de Heer A, Xia W, Bourguignon L . CD44 variant isoforms in head and neck squamous cell carcinoma progression. Laryngoscope. 2009; 119(8):1518-30. PMC: 2718060. DOI: 10.1002/lary.20506. View

11.

Giannini C, Sarkaria J, Saito A, Uhm J, Galanis E, Carlson B . Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme. Neuro Oncol. 2005; 7(2):164-76. PMC: 1871885. DOI: 10.1215/S1152851704000821. View

12.

Mori H, Tomari T, Koshikawa N, Kajita M, Itoh Y, Sato H . CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain. EMBO J. 2002; 21(15):3949-59. PMC: 126155. DOI: 10.1093/emboj/cdf411. View

13.

Sugahara K, Murai T, Nishinakamura H, Kawashima H, Saya H, Miyasaka M . Hyaluronan oligosaccharides induce CD44 cleavage and promote cell migration in CD44-expressing tumor cells. J Biol Chem. 2003; 278(34):32259-65. DOI: 10.1074/jbc.M300347200. View

14.

Trochon V, Mabilat C, Bertrand P, Legrand Y, Smadja-Joffe F, Soria C . Evidence of involvement of CD44 in endothelial cell proliferation, migration and angiogenesis in vitro. Int J Cancer. 1996; 66(5):664-8. DOI: 10.1002/(SICI)1097-0215(19960529)66:5<664::AID-IJC14>3.0.CO;2-4. View

15.

Abecassis I, Olofsson B, Schmid M, Zalcman G, Karniguian A . RhoA induces MMP-9 expression at CD44 lamellipodial focal complexes and promotes HMEC-1 cell invasion. Exp Cell Res. 2003; 291(2):363-76. DOI: 10.1016/j.yexcr.2003.08.006. View

16.

Okamoto I, Kawano Y, Murakami D, Sasayama T, Araki N, Miki T . Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway. J Cell Biol. 2001; 155(5):755-62. PMC: 2150876. DOI: 10.1083/jcb.200108159. View

17.

Spessotto P, Rossi F, Degan M, di Francia R, Perris R, Colombatti A . Hyaluronan-CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9. J Cell Biol. 2002; 158(6):1133-44. PMC: 2173214. DOI: 10.1083/jcb.200202120. View

18.

Martin T, Harrison G, Mansel R, Jiang W . The role of the CD44/ezrin complex in cancer metastasis. Crit Rev Oncol Hematol. 2003; 46(2):165-86. DOI: 10.1016/s1040-8428(02)00172-5. View

19.

Turpeenniemi-Hujanen T . Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers. Biochimie. 2005; 87(3-4):287-97. DOI: 10.1016/j.biochi.2005.01.014. View

20.

Samanna V, Wei H, Ego-Osuala D, Chellaiah M . Alpha-V-dependent outside-in signaling is required for the regulation of CD44 surface expression, MMP-2 secretion, and cell migration by osteopontin in human melanoma cells. Exp Cell Res. 2006; 312(12):2214-30. DOI: 10.1016/j.yexcr.2006.03.022. View